{"id":11027,"date":"2026-05-26T19:00:00","date_gmt":"2026-05-26T17:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=8ceab98201791b5893b338af7604a294"},"modified":"2026-05-26T19:00:00","modified_gmt":"2026-05-26T17:00:00","slug":"epocrates-and-deepintent-announce-first-to-market-partnership-for-programmatic-access-across-point-of-care-advertising","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=11027","title":{"rendered":"epocrates and DeepIntent Announce First-to-Market Partnership for Programmatic Access Across Point-of-Care Advertising"},"content":{"rendered":"

\nEnabling advertisers to engage clinicians with real-time clinical intent directly within their workflow<\/i><\/p><\/a><\/a>

BOSTON--(BUSINESS WIRE)--epocrates, a leading digital platform for clinicians, today announced a first-of-its-kind partnership with DeepIntent, the leading healthcare demand-side platform (DSP), to bring powerful point-of-care advertising into the epocrates\u2019 clinician workflow for the first time.<\/p>

\nFor over 25 years, epocrates has been a leading source of clinical intelligence for healthcare providers, delivering validated, actionable medication insights at the point of care. Its AI-powered intelligence platform helps clinicians access actionable insights faster than ever before and with highly granular engagement metrics that brand teams can use to deliver even more precise and relevant data.<\/p>

\nThis collaboration marks the first time epocrates\u2019 high-value clinical inventory has been made programmatically available<\/b>, giving advertisers direct access to healthcare professionals (HCPs) in the preeminent decision platform.<\/p>

\n\u201cFor years, programmatic access in healthcare has focused on where care happens\u2014not how decisions are made,\u201d said David Minkin, President and General Manager of epocrates. \u201cTogether with DeepIntent, we\u2019re changing that. This partnership brings programmatic access directly into the clinician workflow, enabling engagement at the moment clinical decisions are happening.\u201d<\/p>

\nA New Standard for Point-of-Care Programmatic<\/b><\/p>

\nWhile much of the industry has defined point-of-care media through place-based environments, epocrates represents a fundamentally different model\u2014one built around clinical utility, real-time intent, and deterministic HCP identity<\/b>.<\/p>

\nWith more than one million active, prescribing clinicians and hundreds of thousands of daily drug reference interactions, epocrates provides a uniquely high-intent environment\u2014one that closely reflects the clinical decision-making process.<\/p>

\nThrough this partnership, DeepIntent becomes the first demand-side platform (DSP) to activate campaigns within the epocrates environment<\/b>, enabling advertisers to:<\/p>